EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Cognitive and neurodegenerative trajectories of subjective cognitive decline according to baseline biomarkers: Results of the CoSCo study

Yun Jeong Hong, Seong Hye Choi, SangYun Kim, Jee Hyang Jeong, Kee Hyung Park, Min Jeong Wang, Sungmin Kang, Dong Won Yang, CoSCo study group

Alzheimer's & Dementia · 2025

DOI: 10.1002/alz.14473 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Yun Jeong Hong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Neurology, Uijeongbu St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Alzheimer Disease, Cognitive Dysfunction. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT), Ministry of Health and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Alzheimer's disease (AD) is now diagnosed biologically. Since subjective cognitive decline (SCD) may indicate preclinical AD, assessing AD‐biomarkers is crucial. We investigated cognitive and neurodegenerative trajectories in SCD over 24 months based on biomarker positivity, and evaluated the predictive value of plasma biomarkers. METHODS The CoSCo prospective cohort included older adults with SCD. Participants were categorized into high‐ and low‐risk groups based on plasma biomarkers (amyloid beta [Aβ] 42/40, phosphorylated tau 181 [p‐tau181], and glial fibrillary acidic protein [GFAP]), and magnetic resonance imaging (MRI) findings to compare outcomes. RESULTS High‐risk SCDs ( n = 23, 23%) revealed greater decline in general cognition, memory recall, frontal function, and hippocampal volumes compared to low‐risk SCDs. Combined scores of plasma and MRIs yielded the best predictions compared with other biomarker categories. DISCUSSION SCD participants with high‐risk experience faster cognitive and neurodegenerative declines. A combination of plasma biomarkers and MRIs could be used for screening and prognosis. Highlights This is part of a multicenter prospective cohort study in Korea. We investigated cognitive and atrophic trajectories in SCD over 24 months. High risk SCDs revealed greater cognitive decline and hippocampal atrophy. Integration of plasma and MRIs yielded better predictions than other categories. Risk stratification using plasma and MRIs can be used for screening and prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseCognitive DysfunctionAgedFemaleHumansMaleAmyloid beta-PeptidesBiomarkersBrainCohort StudiesGlial Fibrillary Acidic ProteinHippocampusMagnetic Resonance ImagingNeuropsychological TestsPeptide FragmentsProspective StudiesRepublic of Koreatau ProteinsLongitudinal Studies

Stichwörter der Autor:innen

Alzheimer's diseasecognitive declinecohort studyplasma biomarkersubjective cognitive decline

Substanzen

Amyloid beta-PeptidesBiomarkersGlial Fibrillary Acidic ProteinPeptide Fragmentstau Proteins

Autor:innen und Institutionen

  • Neurology, Uijeongbu St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea.
  • Neurology, Inha University College of Medicine, Incheon, Republic of Korea.
  • Neurology, Seoul National University College of Medicine and Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
  • Neurology, Ewha Womans University Seoul Hospital, Ewha Womans University College of Medicine, Seoul, Republic of Korea.
  • Neurology, College of Medicine, Gachon University Gil Medical Center, Incheon, Republic of Korea.
  • Neurology, ROA clinic, Seongnam, Republic of Korea.

Förderung

  • National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT)
  • Ministry of Health and Welfare

Zitieren

APA

Hong, Y. J., Choi, S. H., Kim, S., Jeong, J. H., Park, K. H., Wang, M. J., Kang, S., Yang, D. W., & CoSCo study group (2025). Cognitive and neurodegenerative trajectories of subjective cognitive decline according to baseline biomarkers: Results of the CoSCo study. Alzheimer's & Dementia. https://doi.org/10.1002/alz.14473

Vancouver

Hong YJ, Choi SH, Kim S, Jeong JH, Park KH, Wang MJ, et al. Cognitive and neurodegenerative trajectories of subjective cognitive decline according to baseline biomarkers: Results of the CoSCo study. Alzheimer's & Dementia. 2025. doi:10.1002/alz.14473

BibTeX
@article{Hong2025,
  author = {Hong, Yun Jeong and Choi, Seong Hye and Kim, SangYun and Jeong, Jee Hyang and Park, Kee Hyung and Wang, Min Jeong and Kang, Sungmin and Yang, Dong Won and CoSCo study group, CoSCo study group},
  title = {Cognitive and neurodegenerative trajectories of subjective cognitive decline according to baseline biomarkers: Results of the CoSCo study},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  doi = {10.1002/alz.14473}
}
Kostenlos starten →